Please login to the form below

Not currently logged in
Email:
Password:

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

QiC Excellence in Oncology

Finalists for the first QiC Excellence in Oncology awards have been announced, each demonstrating an example of good practice in cancer care throughout the UK.

In total, there are 39 finalists spanning 10 categories, including the cancer commissioning award, cancer team of the year and patient experience.

Represented among the finalists in cancer charity initiative of the year were Macmillan Cancer Support, testicular cancer awareness campaign It's in the Bag and HeadSmart to raise awareness of brain tumours.

And those down to final five for cancer journalist of blogger of the year included Linda Geddes of New Scientist, freelance writer Judy Hobson and cancer blogger Mike Baker.

QiC Excellence in Oncology is an evolution of Pfizer's Excellence in Oncology awards, and aims to recognise individuals or teams involved in the support, care and treatment of cancer patients in the UK.

It is supported by Cancer 52, Beating Bowel Cancer, the National Cancer Action Team, and has industry partners such as Pfizer, BMS and Novartis.

Winners will be announced on November 6 at The Hilton, Liverpool, during the National Cancer Research Institute's (NCRI) annual conference.

14th September 2012

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield Commercial & Medical Services

Ashfield Commercial & Medical Services, part of UDG Healthcare plc, is a leading international provider of services to healthcare manufactures...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...